View Older Stories View More Recent Stories
-
Palatin Technologies (PTN) Prices $16.5M Common Stock, Warrants Offering
-
Palatin Technologies Announces Pricing of Public Offering of Common Stock and Warrants
-
Palatin Technologies (PTN) Confirms Proposed Offering of Common Stock and Warrants
-
Palatin Technologies Announces Proposed Public Offering of Common Stock and Warrants
-
Roth Capital Halves PT on FuelCell (FCEL) to $2 Amid CT-DEEP Rejection
-
Roth Capital Cuts PT on ReneSola (SOL) to 65c Amid Q3 Miss, Weak Outlook
-
Streetinsider.com's Hot Lunchtime Reads 11/29: (FB) (TIF) (VBLT) (LLL)
-
Roth Capital Affirms Vascular Biogenics (VBLT) at 'Buy' Following Topline VB-111 Phase 2 Data
-
Notable Analyst Rating Changes 11/29: (GS) (PFE) (VCYT) Upgraded; (DLPH) (GEF) (KIM) Downgraded
-
Roth Capital Cuts PT on Plug Power (PLUG) to $1.40; Sees ITC as Primary Upcoming Catalyst
-
ROTH Capital Partners to Host New Industrials Corporate Access Day in New York City
-
Cherokee (CHKE) Prices 3.685M Share Stock Offering for Proceeds of ~$35M; Enters Hi-Tec Acquisition Documents
-
Dataram (DRAM) Announces Finalization of U.S. Gold Corp. Acquisition
-
Cherokee Inc. Announces Entry into Hi-Tec Acquisition Documents and Pricing of Public Offering of Common Stock
-
Dataram Corporation Finalizes Agreement to Acquire U.S. Gold Corp.
-
Ameresco to Attend Investor Conferences in December
-
Roth Capital Starts Azure Power Global Limited (AZRE) at Buy
-
Cherokee (CHKE) to Offer Common Stock; Announces Preliminary Financial Results
-
BioPharmX Corporation Announces Closing of a $12.5 Million Unit Offering
-
Cherokee Global Brands Announces Launch of Public Offering of Common Stock
-
Avino Announces Closing of Bought Deal Offering
-
Roth Capital Cuts Price Target on Hanwha Q CELLS (HQCL) to $10 Following 3Q and Guidance
-
Roth Capital Keeps Lion Bio (LBIO) at 'Buy' Following Juno's (JUNO) ROCKET Study Update
-
PDL BioPharma Issues $150.0 Million of 2.75% Convertible Senior Notes Due 2021
-
Roth Capital Affirms BioLineRx (BLRX) at 'Buy' Following Q3 Results
-
BioPharmX (BPMX) Prices Net $11.7M Unit Offering
-
BioPharmX Corporation Announces Pricing of Unit Offering
-
Amyris to Present at Four Upcoming Investor Conferences in December
-
Roth Capital Cuts PT on Canadian Solar (CSIQ) to $11 Following Q3 Results, Outlook
-
Roth Capital Downgrades Applied Micro Circuits (AMCC) to Neutral
-
Roth Capital Reaffirms Aduro Biotech (ADRO) at 'Buy'; Says Partial Clinical Hold Lift No Surprise
-
Stockholders and Industry Analysts Voice Significant Support for Farmer Bros. Co.'s Turnaround Plan and Leadership Team
-
Roth Capital Positive on Stemline Therapeutics (STML) Ahead of ASH Amid SL-701 'Surprise'
-
Roth Capital Affirms Ligand Pharma (LGND) at 'Buy' Following Presentation of New Phase 2 DUET Data (RTRX)
-
Roth Capital Affirms First Solar (FSLR) at 'Neutral' Amid Transition, Guidance Update
-
PDL BioPharma (PDLI) Announces Pricing of Aggregate $150M Conv. Notes Offering
-
PDL BioPharma Prices Public Offering of $150.0 Million of 2.75% Convertible Senior Notes Due 2021
-
AmpliPhi Biosciences (APHB) Prices Common Stock, Warrants Offering for Net Proceeds of $3.8M
-
AmpliPhi Biosciences Announces Pricing of Public Offering of Common Stock and Warrants
-
Roth Capital Starts Guidance Software (GUID) at Buy
-
Roth Capital Affirms Daqo New Energy (DQ) at 'Buy'; Lower Costs to Drive Results
-
Roth Capital Affirms Palatin Technologies (PTN) at 'Buy'; Q1 Solid and Partnership Potential is Robust
-
Frankly Files Form S-1 Registration Statement
-
Roth Capital Downgrades SolarEdge Technologies (SEDG) to Neutral
-
MeetMe to Participate at the ROTH Technology Corporate Access Day in New York on November 16, 2016
-
Hannon Armstrong Sustainable Infrastructure Capital, Inc. Announces the Closing of its Public Offering of Common Stock
-
Roth Capital Sees Downside in Solars Following Trump Win (SCTY) (FSLR) (TSL) (YGE)
-
Notable Analyst Rating Changes 11/9: (ABC) (X) (PN) Upgraded; (STZ) (GPRO) (JPM) Downgraded
-
Roth Capital Starts Lydall (LDL) at Buy
-
Roth Capital Upgrades Applied Genetic Technologies Corp. (AGTC) to Buy

